Ascendis Pharma A/S Common Stock

As of the most recent data (June 2026), ASND shows a common stock of $8.9M. That compares with $8.2M in the prior-year period — up 8.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ASND's common stock is now $8.9M (was $8.2M) — a 8.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Ascendis Pharma A/S is outperforming or lagging.

Tracking ASND's common stock over time shows whether Ascendis Pharma A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $8.9M That compares with $8.2M in the prior-year period — up 8.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Ascendis Pharma A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $8.9M) with ownership activity and broader fundamentals.

Ascendis Pharma A/S's common stock is $8.9M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.